Speaker
Anne Behr, BSN, RN, ACRN
Nurse Clinical Educator
West Virginia University
Learning Objectives:
- Discuss how long-acting injectables (LAI) play an important role adherence
- Discuss the assessment of patients as candidates for LAI treatment
- Identify the prescribing and monitoring guidelines of cabotegravir and lenacapavir for treatment and prevention of HIV
- List resources for preparation and administration of LAIs to patients
- Identify approaches to patient education about LAI treatment
Accreditation:
- Certificate of Attendance
- The MidAtlantic AIDS Education and Training Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association Approver Unit an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This event is eligible for 1.5 credit hours.
In order to receive a certificate of attendance or continuing education, all required evaluations must be completed in a timely manner.
Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of their state licensing board(s).
Acknowledgement:
The MidAtlantic AIDS Education and Training Center (MAAETC) is supported by DHHS, Health Resources and Services Administration (HRSA) as part of a grant (grant number TR7HA53201) totalling $3,463,090.00 million and 0% financed with non-governmental sources.
The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade names for products mentioned are for training and identification purposes only. The contents of this material are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.
